Plasma cell diversity | Using single cell profiling to understand the biology of long-term immunity
Researchers at the Allen Institute are taking on the complex questions of human immunology in a big way—using foundational science on a large scale to reveal driving factors in disease response and long-term immunity. Dr. Peter Skene, Director of High Resolution Translational Immunology, and members of his team discuss their work, currently focused on plasma cell diversity and the downstream implications for human health. Get an inside look at how they approach these complex questions with scRNA-seq and spatial transcriptomics, including high-throughput experiments powered by Chromium Single Cell Gene Expression Flex. This highly sensitive assay allows them to obtain a wealth of data to develop a more comprehensive understanding of plasma cell phenotypes and their interactions with other immune cells.